Zhou Y - Search Results

1

FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma.

Zhou Y, Shen X, Zhang S, Pu X, Xu Z, Zhao X, Feng W, Liang Y, He X, Yang A, Qiu Y, Yuan Y, Chen C, Chen J. Zhou Y, et al. Adv Sci (Weinh). 2026 Jan;13(3):e10782. doi: 10.1002/advs.202510782. Epub 2025 Oct 30. Adv Sci (Weinh). 2026. PMID: 41164952 Free PMC article.

2

High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.

Zhou Y, Gu Q, Zhu L, Zhang S, Wu H, Pu X, Jiang C, Chen J. Zhou Y, et al. Cell Prolif. 2023 Dec;56(12):e13513. doi: 10.1111/cpr.13513. Epub 2023 Jul 3. Cell Prolif. 2023. PMID: 37401015 Free PMC article.

3

Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.

Liang Y, Zhang R, Biswas S, Bu Q, Xu Z, Qiao L, Zhou Y, Tang J, Zhou J, Zhou H, Lu L. Liang Y, et al. Among authors: zhou h, zhou y, zhou j. Cell Prolif. 2024 Apr;57(4):e13576. doi: 10.1111/cpr.13576. Epub 2023 Nov 22. Cell Prolif. 2024. PMID: 37994257 Free PMC article.

4

Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.

Zhu L, Tang N, Hang H, Zhou Y, Dong J, Yang Y, Mao L, Qiu Y, Fu X, Cao W. Zhu L, et al. Among authors: zhou y. Cancer Lett. 2024 Apr 1;586:216611. doi: 10.1016/j.canlet.2024.216611. Epub 2024 Feb 1. Cancer Lett. 2024. PMID: 38309617

5

CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway.

Zhou Y, Qiu J, Liu S, Wang P, Ma D, Zhang G, Cao Y, Hu L, Wang Z, Wu J, Jiang C. Zhou Y, et al. Cancer Med. 2023 Jan;12(1):425-444. doi: 10.1002/cam4.4919. Epub 2022 Jul 21. Cancer Med. 2023. PMID: 35861040 Free PMC article.

6

Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR-211-5p/CREB5 axis.

Qiu J, Wang P, Chen Z, Zhou Y, Zhang G, Wang Z, Wu J, Zhu Q, Jiang C. Qiu J, et al. Among authors: zhou y. Cancer Med. 2023 Apr;12(7):8388-8402. doi: 10.1002/cam4.5559. Epub 2022 Dec 23. Cancer Med. 2023. PMID: 36565037 Free PMC article.

7

Circ_0050444 represses esophageal squamous cell carcinoma progression through sponging miR-486-3p to upregulate C10orf91.

Zhang D, Zhou Y, Jiao C, Kong H, Zhao Z, Li Y. Zhang D, et al. Among authors: zhou y. Cell Cycle. 2024 Mar;23(6):693-702. doi: 10.1080/15384101.2024.2357909. Epub 2024 Jun 12. Cell Cycle. 2024. PMID: 38867541 Free PMC article.

8

ITLN1 exacerbates Crohn's colitis by driving ZBP1-dependent PANoptosis in intestinal epithelial cells through antagonizing TRIM8-mediated CAPN2 ubiquitination.

Zhao J, Li Y, Ying P, Zhou Y, Xu Z, Wang D, Wang H, Tang L. Zhao J, et al. Among authors: zhou y. Int J Biol Sci. 2025 May 31;21(8):3705-3725. doi: 10.7150/ijbs.105550. eCollection 2025. Int J Biol Sci. 2025. PMID: 40520022 Free PMC article.

9

Analysis of nutritional status and influencing factors in patients with thoracoabdominal aortic dissection receiving 3D printing-assisted stent graft fenestration.

Zhou Y, Xu Y, Cai Y. Zhou Y, et al. J Cardiothorac Surg. 2023 Mar 21;18(1):91. doi: 10.1186/s13019-023-02185-6. J Cardiothorac Surg. 2023. PMID: 36945041 Free PMC article.

10

CircMAPK9 promotes adipogenesis through modulating hsa-miR-1322/FTO axis in obesity.

Chen S, Song P, Wang Y, Wang Z, Xue J, Jiang Y, Zhou Y, Zhao J, Tang L. Chen S, et al. Among authors: zhou y. iScience. 2023 Aug 28;26(10):107756. doi: 10.1016/j.isci.2023.107756. eCollection 2023 Oct 20. iScience. 2023. PMID: 37692283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,523 results

Search Page

Filters